| Dr William Robison Iv, OD | |
|
3902 13th Ave S, Fargo, ND 58103-3357 | |
| (701) 277-3140 | |
| Not Available |
| Full Name | Dr William Robison Iv |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 3902 13th Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376278556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 796 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Robison Iv, OD 625 2nd Ave N Unit 32, Fargo, ND 58102-6125 Ph: (253) 223-6100 | Dr William Robison Iv, OD 3902 13th Ave S, Fargo, ND 58103-3357 Ph: (701) 277-3140 |
News Archive
The University of Texas at El Paso's Border Biomedical Research Center will accelerate its quest to understand and identify the reasons for Hispanic cancer health disparities and its ultimate impact on the people of the Paso del Norte region thanks to a five-year, $19.2 million grant from the National Institutes of Health.
The number of registered organ and tissue donors in California has reached the nation-leading seven million mark, it was announced today by California Assembly Speaker John A. Pérez (D-Los Angeles), the Donate Life California Organ & Tissue Donor Registry, and the California Department of Motor Vehicles.
How does the heart attain its characteristic shape? Shape may be sculpted by cell movement, cell division, or changes in cell size and shape, all of which can be influenced by the local environment. The heart appears as a simple tube early in development; later, the tube walls bulge outward to form the cardiac chambers.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
› Verified 7 days ago
Vivid Vision Care, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 3265 45th St S Ste 104, Fargo, ND 58104 Phone: 701-741-2951 | |
Barbra Brigitte Brookshire, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3902 13th Ave S, Fargo, ND 58103 Phone: 701-282-5880 Fax: 701-282-8414 | |
Todd L Metzger, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1702 University Dr S, Fargo, ND 58103 Phone: 701-364-3300 Fax: 701-364-8906 | |
Andrew Viet Pham, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1801 45th St S, Fargo, ND 58103 Phone: 701-492-3937 | |
Blaine G Zieman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2400 32nd Ave S, Fargo, ND 58103 Phone: 701-234-3600 Fax: 701-234-3672 | |
Daniel John Levin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1100 19th Ave N Ste L&m, Fargo, ND 58102 Phone: 701-365-1150 | |
Dr. Matthew T Sanders, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4344 20th Ave S, # 1, Fargo, ND 58103 Phone: 701-293-8242 |